awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38965214-A558FC4E-08BE-4592-85CE-6F4A851C865D
Q38965214-A558FC4E-08BE-4592-85CE-6F4A851C865D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38965214-A558FC4E-08BE-4592-85CE-6F4A851C865D
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis.
P2860
Q38965214-A558FC4E-08BE-4592-85CE-6F4A851C865D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38965214-A558FC4E-08BE-4592-85CE-6F4A851C865D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
04f7ad06f313fb86e85c878c84e8193eac190ec1
P2860
Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial.